SCHEMBL7673201

SCHEMBL7673201

CCOC(=O)c1[nH]c2ccccc2c1-c1ccc(Cl)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.74
HPGD P15428 3/20 0.74
CYP1A2 P05177 1/20 0.74
XBP1 P17861 1/20 0.74
CYP2C19 P33261 1/20 0.74
MDM2 Q00987 3/20 0.57
CSF1R P07333 1/20 0.57
MDM4 O15151 1/20 0.56
TSHR P16473 1/20 0.56
HSD17B10 Q99714 1/20 0.56
MEN1 O00255 1/20 0.56
LMNA P02545 1/20 0.56
MAPT P10636 1/20 0.56
KMT2A Q03164 1/20 0.56
TP53 P04637 2/20 0.55
KDM4E B2RXH2 5/20 0.55
HTR6 P50406 2/20 0.55
TUBB4A P04350 2/20 0.54
TUBB P07437 2/20 0.54
TUBA3C P0DPH7 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2956667 0.89 ALDH1A1 (0.73) ALDH1A1HPGDCYP1A2XBP1CYP2C19
SCHEMBL7679486 0.87 ALDH1A1 (0.60) ALDH1A1HPGDCYP1A2XBP1CYP2C19
SCHEMBL11304644 0.87 ALDH1A1 (0.86) ALDH1A1HPGDCYP1A2XBP1CYP2C19
SCHEMBL11559665 0.87 ALDH1A1 (0.70) ALDH1A1HPGDCYP1A2XBP1CYP2C19
SCHEMBL7560803 0.86 ALDH1A1 (0.73) ALDH1A1HPGDCYP1A2XBP1CYP2C19
SCHEMBL6857725 0.86 HPGD (0.62) ALDH1A1HPGDCYP1A2XBP1CYP2C19
SCHEMBL7676091 0.85 ALDH1A1 (0.58) ALDH1A1HPGDCYP1A2XBP1CYP2C19
SCHEMBL28800459 0.85 ALDH1A1 (1.00) ALDH1A1HPGDCYP1A2XBP1CYP2C19
SCHEMBL11297387 0.85 ALDH1A1 (0.82) ALDH1A1HPGDCYP1A2XBP1CYP2C19
SCHEMBL2715272 0.85 ALDH1A1 (1.00) ALDH1A1HPGDCYP1A2XBP1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US disclosed
US-6323228-B1 INHIBITING ANGIOGENESIS IN A MAMMAL IN RECOGNIZED NEED OF SUCH TREATMENT COMPRISING ADMINISTERING TO THE MAMMAL WITH INDOLE SUBSTITUTED WITH HYDRAZIDES ABBOTT LABORATORIES 2001-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors MKI67, FLT4, IDO1 ALDH1A1 98/4885HPGD 416/4885CYP1A2 1856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.